GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00300105 |
|
Recruitment Status :
Terminated
(The development program has been terminated)
First Posted : March 8, 2006
Last Update Posted : March 17, 2008
|
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Primary Completion Date : | No date given |
| Actual Study Completion Date : | December 2006 |